Healthcare Triangle, Inc. (HCTI)
USD 0.86
(-2.86%)
USD 0.86
(-2.86%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -1.61 Million | -2.6 Million | -7.29 Million | -734.67 Thousand | 3.96 Million |
| Net Income | -12.33 Million | -9.6 Million | -5.95 Million | 2.35 Million | 1.17 Million |
| Depreciation & Amortization | 7.23 Million | 3.37 Million | 1.42 Million | 803.19 Thousand | 776.13 Thousand |
| Deferred income taxes | -2.82 Million | - | 55.34 Thousand | - | - |
| Stock-based compensation | 68 Thousand | 257 Thousand | 52 Thousand | - | - |
| Change in working capital | 3.42 Million | 4.3 Million | -3.95 Million | -3.89 Million | 2.01 Million |
| Other non-cash items | 2.87 Million | -928 Thousand | 1.07 Million | 4.58 Million | -2.08 Million |
| Investing Cash Flow | -13 Thousand | -3.31 Million | -7.62 Million | -477.45 Thousand | -3.64 Million |
| Investments in PPE | -13 Thousand | -3.31 Million | -3.12 Million | -477.45 Thousand | -3.64 Million |
| Acquisitions | - | - | -4.5 Million | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | -13 Thousand | -3.27 Million | -3.05 Million | -477.45 Thousand | -3.64 Million |
| Financing Cash Flow | 1.51 Million | 5.49 Million | 15.28 Million | 1.64 Million | - |
| Debt repayment | -1.01 Million | -194 Thousand | -50.00 | -1.64 Million | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | -142 Thousand | - | - | - |
| Common Stock Issuance | 500 Thousand | 5.88 Million | 1.14 Billion | - | - |
| Other Financing Activities | 1.51 Million | -62 Thousand | -1.12 Billion | 1.64 Million | - |
| Accounts receivables | 2.35 Million | 4.08 Million | -3.27 Million | -2.22 Million | 212.99 Thousand |
| Accounts payables | 472 Thousand | -392 Thousand | -2.47 Billion | -750.38 Thousand | 3.42 Million |
| Inventory | - | - | 2.47 Billion | 750.38 Thousand | -3.42 Million |
| Other working capital | -2.82 Million | 617 Thousand | -674.31 Thousand | -1.66 Million | 1.8 Million |
| Cash at beginning of period | 1.34 Million | 1.77 Million | 1.4 Million | 974.83 Thousand | 655.96 Thousand |
| Cash at end of period | 1.23 Million | 1.34 Million | 1.76 Million | 1.4 Million | 974.83 Thousand |
| Capital Expenditure | -13 Thousand | -3.31 Million | -3.12 Million | -477.45 Thousand | -3.64 Million |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -107 Thousand | -429 Thousand | 366.85 Thousand | 427.87 Thousand | 318.86 Thousand |
| Free Cash Flow | -1.62 Million | -5.91 Million | -10.42 Million | -1.21 Million | 318.86 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.51 Million | -1.86 Million | -5.33 Million | -12.33 Million | -1.94 Million | -1.78 Million |
| Depreciation & Amortization | 534 Thousand | 536 Thousand | 4.84 Million | 7.23 Million | 712 Thousand | 802 Thousand |
| Deferred income taxes | - | - | -7.75 Million | -2.82 Million | 8.25 Million | 73 Thousand |
| Stock-based compensation | 25 Thousand | 26 Thousand | -177 Thousand | 17 Thousand | 20 Thousand | 32 Thousand |
| Change in working capital | -93 Thousand | 1.21 Million | 1.87 Million | 3.42 Million | 1.21 Million | -272 Thousand |
| Other non-cash items | 1.18 Million | -67 Thousand | 7.75 Million | 2.87 Million | -4.12 Million | -73 Thousand |
| Investing Cash Flow | - | - | -6000.00 | -13 Thousand | -5000.00 | 2000.00 |
| Investments in PPE | - | - | -6000.00 | -13 Thousand | -5000.00 | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 663 Thousand | -883 Thousand | -49 Thousand | 1.51 Million | -52 Thousand | 1.08 Million |
| Debt repayment | -293 Thousand | -883 Thousand | -49 Thousand | -1.01 Million | -52 Thousand | -586 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 956 Thousand | - | -500 Thousand | 500 Thousand | - | 500 Thousand |
| Other Financing Activities | 663 Thousand | -883 Thousand | -49 Thousand | 1.51 Million | -52 Thousand | 1.08 Million |
| Accounts receivables | 90 Thousand | 1.14 Million | 960 Thousand | 2.35 Million | 280 Thousand | 1.03 Million |
| Accounts payables | -76 Thousand | 60 Thousand | 792 Thousand | 472 Thousand | 235 Thousand | -381 Thousand |
| Inventory | - | - | -792 Thousand | - | -235 Thousand | 381 Thousand |
| Other working capital | -107 Thousand | 13 Thousand | 919 Thousand | -2.82 Million | 931 Thousand | -1.3 Million |
| Cash at beginning of period | 301 Thousand | 1.23 Million | 75 Thousand | 1.34 Million | 132 Thousand | 267 Thousand |
| Cash at end of period | 29 Thousand | 301 Thousand | 1.23 Million | 1.23 Million | 75 Thousand | 132 Thousand |
| Capital Expenditure | - | - | -6000.00 | -13 Thousand | -5000.00 | - |
| Effect of forex changes on cash | - | - | -57 Thousand | - | 57 Thousand | - |
| Net cash flow / Change in cash | -272 Thousand | -933 Thousand | 1.15 Million | -107 Thousand | -57 Thousand | -135 Thousand |
| Free Cash Flow | -935 Thousand | -50 Thousand | 1.2 Million | -1.62 Million | 4.12 Million | -1.22 Million |
BSX
SYZ
2432
300316
VERO
GRMC